PT91682A - Processo para a preparacao de composicoes farmaceuticas contendo etoposido - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo etoposido

Info

Publication number
PT91682A
PT91682A PT91682A PT9168289A PT91682A PT 91682 A PT91682 A PT 91682A PT 91682 A PT91682 A PT 91682A PT 9168289 A PT9168289 A PT 9168289A PT 91682 A PT91682 A PT 91682A
Authority
PT
Portugal
Prior art keywords
ethoposido
preparation
pharmaceutical compositions
compositions containing
solution
Prior art date
Application number
PT91682A
Other languages
English (en)
Other versions
PT91682B (pt
Inventor
Shreerham Narahari Agharkar
Murray Arthur Kaplan
Gururaj Bykadi
Richard G Corrao
Edward J Bara
Ismat Ullah
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT91682A publication Critical patent/PT91682A/pt
Publication of PT91682B publication Critical patent/PT91682B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT91682A 1988-09-12 1989-09-11 Processo para a preparacao de composicoes farmaceuticas contendo etoposido PT91682B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/243,392 US4927638A (en) 1986-10-08 1988-09-12 Etoposide solutions

Publications (2)

Publication Number Publication Date
PT91682A true PT91682A (pt) 1990-03-30
PT91682B PT91682B (pt) 1995-05-31

Family

ID=22918600

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91682A PT91682B (pt) 1988-09-12 1989-09-11 Processo para a preparacao de composicoes farmaceuticas contendo etoposido

Country Status (14)

Country Link
US (1) US4927638A (pt)
EP (1) EP0359184B1 (pt)
JP (1) JPH02115126A (pt)
KR (1) KR900004322A (pt)
AT (1) ATE83150T1 (pt)
AU (1) AU616049B2 (pt)
DE (1) DE68903814T2 (pt)
DK (1) DK446889A (pt)
FI (1) FI894225A (pt)
GR (1) GR3006501T3 (pt)
IE (1) IE892898L (pt)
IL (1) IL91598A0 (pt)
PT (1) PT91682B (pt)
ZA (1) ZA896916B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910014122A (ko) * 1990-01-19 1991-08-31 디께다 가즈히꼬 에토포시드-2-디메틸아미노 화합물의 동결건조 제제
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
SI1033128T2 (sl) 1993-09-28 2012-02-29 Scherer Gmbh R P Izdelava mehke Ĺľelatinaste kapsule
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
CA2188297C (en) * 1994-04-28 2006-12-19 Frederick Herman Hausheer Lactone stable formulation of camptothecin or 7-ethyl camptothecin
AU6390096A (en) * 1995-07-20 1997-02-18 Pharmacia & Upjohn Company Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
AU4609200A (en) * 1999-01-28 2000-08-18 Shashikant Prabhudas Kurani Novel injectable antimalarial compositions of artemisinin
WO2001095939A1 (en) * 2000-06-12 2001-12-20 Smithkline Beecham Corporation Novel solid dispersion compositions
WO2006034147A2 (en) * 2004-09-16 2006-03-30 Abraxis Bioscience, Inc. Compositions and methods for the preparation and administration of poorly water soluble drugs
US20090252702A1 (en) * 2006-04-24 2009-10-08 Bruce Medical Ab Polymer-based anti-cancer agents
US9011843B2 (en) * 2006-12-14 2015-04-21 Master Supplements, Inc. Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms
AU2015214041B2 (en) 2014-02-07 2018-12-06 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219529A (en) * 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
EP0120907A1 (en) * 1982-10-13 1984-10-10 Aston Molecules Limited Pharmaceutical preparations for use in antitumour therapy
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
JPS60239414A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド溶液の変色抑制方法
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS60239415A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド注射剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤

Also Published As

Publication number Publication date
EP0359184A1 (en) 1990-03-21
AU4130189A (en) 1990-03-15
JPH02115126A (ja) 1990-04-27
ZA896916B (en) 1991-08-28
IE892898L (en) 1990-03-12
AU616049B2 (en) 1991-10-17
GR3006501T3 (pt) 1993-06-30
PT91682B (pt) 1995-05-31
IL91598A0 (en) 1990-04-29
KR900004322A (ko) 1990-04-12
US4927638A (en) 1990-05-22
EP0359184B1 (en) 1992-12-09
DE68903814D1 (de) 1993-01-21
DK446889D0 (da) 1989-09-11
FI894225A (fi) 1990-03-13
ATE83150T1 (de) 1992-12-15
DE68903814T2 (de) 1993-04-08
DK446889A (da) 1990-03-13
FI894225A0 (fi) 1989-09-07

Similar Documents

Publication Publication Date Title
PT91682A (pt) Processo para a preparacao de composicoes farmaceuticas contendo etoposido
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
BR1100658A (pt) Composto heterocìclico, composição farmacêutica na forma de dosagem unitária, e, processo para a preparação de um composto heterocìclico
HUT50339A (en) Process for producing benzoxazole derivatives and pharmaceutical compositions comprising the compounds
PT84416B (pt) Processo para a preparacao de formas de dosagem de libertacao controlada para administracao oral contendo polissacaridos de origem natural
HUT41790A (en) Process for producing beta-amino-purine derivatives and pharmaceutical compositions containing them
HUT41800A (en) Process for producing new beta-lactame antibiotica and pharmaceutical compositions containing them as active agents
PT88225A (pt) Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas
HUT44512A (en) Process for producing bensyl derivatives and pharmaceutical compositions containing them
PT90888A (pt) Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas
HUT42478A (en) Process for producing gamma-carboline derivatives and pharmaceutical compositions containing them
HUT41035A (en) Process for producing cepheme derivatives and pharmaceutical compositions containing them
PT89616A (pt) Processo para a preparacao de composicoes artropodicidas contendo misturas sinergicas de derivados piretroides e butoxido de piperonilo
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
HUT43820A (en) Process for producing n-(-2-((-2-hydroxy-phenyl-)(-phenyl-)-methylene-aminosquare )-ethyl-)-acetamide derivatives and pharmaceutical compositions containing them
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
HUT43848A (en) Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
PT92922A (pt) Processo para a preparacao de composicoes farmaceuticas liquidas contendo derivados de piperidinoalcanol
HUT46030A (en) Process for producing citostatic antracyclin-glycoside derivatives and pharmaceutical compositions containing them
PT92345A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados diterpenoides de labdano e derivados de pirimido(6,1-a)isoquinolina-4-ona

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941122

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960531